JPS60500716A - ウイルス腫瘍遺伝子からの合成ポリペプチド - Google Patents

ウイルス腫瘍遺伝子からの合成ポリペプチド

Info

Publication number
JPS60500716A
JPS60500716A JP59501099A JP50109984A JPS60500716A JP S60500716 A JPS60500716 A JP S60500716A JP 59501099 A JP59501099 A JP 59501099A JP 50109984 A JP50109984 A JP 50109984A JP S60500716 A JPS60500716 A JP S60500716A
Authority
JP
Japan
Prior art keywords
oncobrotiin
polypeptide
cells
synthetic polypeptide
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP59501099A
Other languages
English (en)
Japanese (ja)
Inventor
セン　ア−ラツプ
ラーナー　リチヤード　エイ
ホーテン　リチヤード　エイ
ビトル　ジエイムス　エル
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of JPS60500716A publication Critical patent/JPS60500716A/ja
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57575—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving oncogenic proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/32—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP59501099A 1983-02-14 1984-02-14 ウイルス腫瘍遺伝子からの合成ポリペプチド Pending JPS60500716A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46632983A 1983-02-14 1983-02-14
US466329 1983-02-14

Publications (1)

Publication Number Publication Date
JPS60500716A true JPS60500716A (ja) 1985-05-16

Family

ID=23851346

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59501099A Pending JPS60500716A (ja) 1983-02-14 1984-02-14 ウイルス腫瘍遺伝子からの合成ポリペプチド

Country Status (12)

Country Link
EP (1) EP0119702A3 (enExample)
JP (1) JPS60500716A (enExample)
DE (1) DE3490048T1 (enExample)
ES (1) ES529683A0 (enExample)
GR (1) GR79812B (enExample)
IE (1) IE840286L (enExample)
IL (1) IL70947A (enExample)
NO (1) NO844099L (enExample)
NZ (1) NZ207121A (enExample)
PT (1) PT78077B (enExample)
WO (1) WO1984003087A1 (enExample)
ZA (1) ZA84617B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04500122A (ja) * 1988-08-12 1992-01-09 プロジェンクス・インコーポレイテッド 蛋白リガンドに対するポリペプチド誘発モノクローナル受容体

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1219232A (en) * 1983-08-17 1987-03-17 Richard A. Lerner Polypeptide-induced monoclonal receptors to protein ligands
US5030565A (en) * 1983-08-17 1991-07-09 Scripps Clinic And Research Foundation Polypeptide-induced monoclonal receptors to protein ligands
US5733738A (en) * 1983-08-17 1998-03-31 Ligand Pharmaceuticals Polypeptide-induced monoclonal receptors to protein ligands
US4663436A (en) * 1984-04-24 1987-05-05 Scripps Clinic And Research Foundation Leukemia-associated virus immunogen, vaccine and assay
US4794168A (en) * 1984-04-24 1988-12-27 Scripps Clinic And Research Foundation Leukemia-associated virus immunogen, vaccine and assay
EP0177814A3 (en) * 1984-09-19 1987-12-02 Cetus Corporation Peptide antibodies and their use in detecting oncogene products
US4762706A (en) * 1984-10-17 1988-08-09 Cetus Corporation Peptide antibodies and their use in detecting oncogene products
US4798787A (en) * 1984-09-19 1989-01-17 Cetus Corporation Peptide antibodies and their use in detecting oncogene products
US6200764B1 (en) 1985-01-29 2001-03-13 Bayer Corporation Detection, quantitation and classification of ras proteins in body fluids and tissues
US5081230A (en) * 1987-07-08 1992-01-14 E. I. Dupont Denemours And Company Monoclonal antibodies reactive with normal and oncogenic forms of the ras p21 protein
US5443956A (en) * 1985-01-29 1995-08-22 Oncogene Science, Inc. Detection, quantitation and classification of RAS proteins in body fluids and tissues
US5084380A (en) * 1985-01-29 1992-01-28 Applied Biotechnology Monoclonal antibodies reactive with activated and oncogenic ras p21 proteins
US5028527A (en) * 1988-02-22 1991-07-02 Applied Bio Technology Monoclonal antibodies against activated ras proteins with amino acid mutations at position 13 of the protein
US4898932A (en) * 1985-01-29 1990-02-06 E. I. Du Pont De Nemours And Company Monoclonal antibodies reactive with activated and oncogenic ras p21 proteins
EP0203587A3 (en) * 1985-05-30 1989-08-09 F. Hoffmann-La Roche Ag Ras oncogene peptides and antibodies
EP0206065A3 (en) * 1985-06-27 1989-04-19 James R. Feramisco Method of detecting oncogene and proto-oncogene related proteins in extracellular biological fluids
EP0267275A4 (en) * 1986-05-21 1989-09-19 Cold Spring Harbor Lab DNA SEQUENCE, CODING FOR -I (ROS) ONCOGEN, CODED POLYPEPTIDES THEREOF AND DETECTING METHODS BASED THEREFORE.
US5320941A (en) * 1986-06-06 1994-06-14 Dallan Young DNA sequence encoding mas onhcogene, polypeptides encoded therefrom and diagnostic and other methods based therefrom
JPS6374492A (ja) * 1986-09-18 1988-04-04 Hiroshi Shiyuku モノクロ−ナル抗体
US6365151B1 (en) 1996-01-19 2002-04-02 Philadelphia Health And Educational Corporation Cellular immunogens comprising cognate proto-oxogenes
GB0014870D0 (en) * 2000-06-16 2000-08-09 King S College London Peptides
WO2015103643A2 (en) 2014-01-06 2015-07-09 The General Hospital Corporation Integrin antagonists

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4180499A (en) * 1971-01-27 1979-12-25 Hoffmann-La Roche Inc. Carcinoembryonic antigens
US4132769A (en) * 1974-10-30 1979-01-02 Osther Kurt B Cancer antigen, cancer therapy, and cancer diagnosis
US4075194A (en) * 1976-12-09 1978-02-21 Yeda Research And Development Co., Ltd. Novel synthetic undecapeptide and clinical assay
US4410510A (en) * 1980-03-10 1983-10-18 Virginia Livingston-Wheeler Method for preparing a purified extraction residue fraction and its use in stimulating the immune response
US4406885A (en) * 1978-12-28 1983-09-27 Research Corporation Preparation of native oncornavirus envelope subunits and vaccines therefrom
SE447263B (sv) * 1979-04-20 1986-11-03 Bonnierfoeretagen Ab Syntetisk, antigeniskt aktiv polypeptid och antigeniskt medel innehallande nemnda polypeptid
CA1252046A (en) * 1982-11-04 1989-04-04 Martin J. Cline Methods for oncogenic detection

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04500122A (ja) * 1988-08-12 1992-01-09 プロジェンクス・インコーポレイテッド 蛋白リガンドに対するポリペプチド誘発モノクローナル受容体

Also Published As

Publication number Publication date
EP0119702A2 (en) 1984-09-26
NO844099L (no) 1984-10-12
ES8601704A1 (es) 1985-11-16
ES529683A0 (es) 1985-11-16
EP0119702A3 (en) 1988-01-07
WO1984003087A1 (en) 1984-08-16
IL70947A (en) 1987-11-30
PT78077A (en) 1984-03-01
NZ207121A (en) 1988-05-30
IE840286L (en) 1984-08-14
ZA84617B (en) 1984-09-26
GR79812B (enExample) 1984-10-31
IL70947A0 (en) 1984-05-31
PT78077B (en) 1986-03-20
DE3490048T1 (de) 1985-07-11

Similar Documents

Publication Publication Date Title
JPS60500716A (ja) ウイルス腫瘍遺伝子からの合成ポリペプチド
CA1194794A (en) Synthetic peptide specific antigenic determinant and method of manufacturing antigenic materials therefrom
US5196510A (en) Molecular recognition units
KR100547049B1 (ko) 바이러스 감염증 치료를 위한 조성물 및 방법
EP0152477B1 (en) Polypeptide-induced monoclonal antibodies to oncoproteins
US4798787A (en) Peptide antibodies and their use in detecting oncogene products
CA1257540A (en) Peptide antibodies and their use in detecting oncogene products
US5563247A (en) Monoclonal antibodies to oncoproteins and methods of making monoclonal antibodies
JPS62500027A (ja) エプスタイン、バールウィルス核抗原と免疫反応する抗体を産生する化学的に合成されたポリペプチド
Strand et al. Structural proteins of mammalian oncogenic RNA viruses: immunological characterization of the p15 polypeptide of Rauscher murine virus
CS275838B6 (en) Method for production of hybridoms used for monoclonal antigen against hiv virus producing
JPH07502484A (ja) 哺乳動物免疫不全ウイルスの検出
US7541036B2 (en) Human immunodeficiency virus type 1 (HIV-1) matrix (MA or p17) polypeptide capable of inducing anti-p17 antibodies that neutralize the proinflammatory activities of the MA protein
Muller et al. Specificity of antibodies raised against triacetylated histone H4
KR910002690B1 (ko) Htlv-ⅲ 바이러스 관련 펩티드, 이에 대한 항체, 백신, aids바이러스에 대한 수동 및 자동 면역 및 aids바이러스의 혈청학적 진단을 위한 진단 시험
Zauner et al. Identification of the polypeptide encoded by the URF‐1 gene of Neurospora crassa mtDNA
EP0177814A2 (en) Peptide antibodies and their use in detecting oncogene products
Sherr et al. Characterization of a feline sarcoma virus-coded antigen (FOCMA-S) by radioimmunoassay.
CA1341391C (en) Protective peptides derived from human immunodeficiency virus-1 gp160
JPH08510714A (ja) エプスタイン−バーウィルスからの免疫反応性ペプチド
JP2001506578A (ja) 複合ペプチド、それを含む免疫製剤および免疫疾患を処置するためのそれらの使用
JPS63264600A (ja) ウシ白血病ウイルスに対する感染防御抗体を誘導するペプチド分画と、この分画を得る方法と、この分画の遺伝暗号配列と、この分画から製造されるワクチン
JPS62500592A (ja) リンパ節症及び後天性免疫不全症候群のウイルスの抗原，特にエンベロ−プ抗原，及びウイルス，ウイルスエンベロ−プ抗原の産生方法，免疫原組成物の調製用叉は該ウイルスに対する抗体の存在の診断用としての該抗原の
JPH09508014A (ja) ウマ動脈炎ウイルスペプチド、該ペプチドに対する抗体、及びこれらの診断検査での使用
KR900008014B1 (ko) 펩타이드 항체의 제조방법